Partner news
News
Partner news
Bioasis Enters Into Research Collaboration With Janssen
Read full storyPartner news
Collaboration with Johnson & Johnson Innovation to jump-start search for new malaria drugs
Read full storyPartner news
Teneobio Announces Achievement of Milestone Payment as Janssen Advances Phase I Study of Bispecific JNJ-75348780 for the Treatment of NHL and CLL
Read full storyPartner news
Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza
Read full storyPartner news
Philogen Announces Options Exercise by Janssen
Read full storyPartner news
RefleXion Raises $100 Million for Cancer Treatment Commercialization
Read full storyPartner news
Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies
Read full storyPartner news
Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platform
Read full storyJNJ Press releases
Johnson & Johnson Innovation Announces Collaboration with National Academy of Medicine to Help People Live Longer, Healthier Lives
Read full storyPartner news
HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing
Read full storyJNJ Press releases
Johnson & Johnson Innovation and Children’s National Health System* to Launch JLABS @ Washington, DC at the new Children’s National Research and Innovation Campus in 2020
Read full storyPartner news
BlackThorn Therapeutics Announces Positive Phase 1 Results for Its Selective KOR Antagonist, BTRX-335140
Read full storyPartner news
Joint Purification Systems, Inc. Announces $7.8 Million Series A Financing
Read full storyPartner news